City

Los Angeles (1)

San Diego (1)

San Francisco (1)

Shanghai (1)

Condition

Pancreatic Neuroendocrine Neoplasm (2)

Overall Status

Not yet recruiting (2)

Sign in for free

Phase

phase 2 (1)

Sponsor

Fudan University (1)

University of California, San Francisco (1)

Collaborator

Univeristy of California Pancreatic Cancer Consortium (UCPCC) (1)

Intervention

hereditary cancer panel (1)

nimotuzumab (1)

Study Documents

Intervention Type

diagnostic test (1)

drug (1)

Funder Type

Other (2)

Study Type

Interventional (1)

Observational (1)

pancreatic neuroendocrine neoplasm

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Genetic Predisposition Testing Program for Pancreatic

Not yet recruiting

Pancreatic Neuroendocrine Neoplasm

Hereditary Cancer Panel

Los Angeles, California
+2 more

Feb 17, 2023

Pancreatic Neuroendocrine Tumor Trial in Shanghai (Nimotuzumab)

Not yet recruiting

Pancreatic Neuroendocrine Neoplasm

Nimotuzumab

Shanghai, Shanghai, China

Department of Pancreatic Surgery, Fudan University Shanghai Canc

Apr 4, 2022